AlloStim (AlloStim)
Other Medications
Description
AlloStim is a personalized immunotherapy that utilizes allogeneic T-cells to stimulate anti-tumor immune responses in patients with metastatic colorectal cancer. This cellular immunotherapy is designed to enhance the patient's immune system recognition and destruction of cancer cells. AlloStim can be administered as monotherapy or in combination with cryoablation procedures to create an in-situ vaccine effect at tumor sites.
Mechanism of Action
AlloStim works by introducing allogeneic (donor-derived) T-cells that have been processed to stimulate the patient's immune system against tumor antigens. The treatment aims to overcome immune tolerance and activate both innate and adaptive immune responses against colorectal cancer cells, particularly in patients with KRAS and BRAF mutations where traditional targeted therapies may be less effective.
Molecular Targets
Side Effects
Not all side effects are listed. Side effects vary by individual. Always consult your oncologist.
Clinical Trials
Quick Info
| Brand Name | AlloStim |
| Category | Other Medications |
 Status | Experimental |
 Estado EMA | Experimental |
 Acceso España | med_spain_not_available |
| Administration | Intramuscular |
| Clinical Trials | 3 |
Related Medications
Medical Disclaimer
This information is for educational purposes only and should not replace professional medical advice. Always consult your healthcare team before making treatment decisions.